IMEIK | Briefing, News, Analysis, Research, Data

IMEIK

IMEIK is a leading Chinese biomedical soft tissue repair materials manufacturer.

IMEIK, founded in 2004, has been developed based on the research, development, and transformation of biomedical soft tissue repair materials. The founder is Jian Jun. Listed on the Shanghai Stock Exchange in September 2020, the company's major shareholders are Jian Jun, Ningbo Zhixingjun Investment Management Limited Partnership, and GANNETT PEAK LIMITED. Rivals with the direct and indirect competition with IMEIK include Haohai Biological, Bloomage BioTech.

Sector

Healthcare

Industry

General Healthcare

Sub-industry

General Healthcare

Founded

Jun 9, 2004

HQ location

Beijing, China

Legal name

IMEIK Technology Development Co., Ltd.

Website

http://www.imeik.com/

ir@imeik.com

Employees

101-300

All
News
Analysis
Research

Briefing Jun 28, 2022 04:05 PM · Technology | Consumer Staples | Healthcare

Malaysia will consider reducing and exempting taxes from the agricultural and food sectors.

Briefing Jun 20, 2022 11:20 AM · Technology | Communication | Healthcare

"Strange fire technology" obtained tens of millions of yuan of angel round financing

In-depth

Healthcare

China VC Investment List Q4 2022 – Healthcare

For healthcare, we at EqualOcean have identified 20 companies worth watching in Q4 identified by proceedings. We select venture capital investments of over CNY 200 million on average or the equivalent value in USD in a single round.

Jan 05, 2023 06:55 PM

Briefing May 23, 2022 12:38 PM · Healthcare

Aimeike signs distribution cooperation framework agreement with South Korea huons BP

Briefing Apr 26, 2022 04:15 PM · Communication | Healthcare

Luoxin pharmaceutical: delayed disclosure of the first quarter report of 2022

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare

China's Aesthetic Medicine Body Contouring Industry

Apr 18, 2022 06:30 PM

Briefing Feb 25, 2022 09:58 AM · Healthcare

The steel sector strengthened significantly

Briefing Dec 09, 2021 10:39 AM

Baijiu plate strength, mouth cellar line exceeds 10%

Briefing Oct 22, 2021 10:13 PM · Real Estate

AMEC: the capital increase and acquisition of part of the equity of hoons biopharma in South Korea have been completed

Briefing Oct 19, 2021 07:22 PM · Technology | Healthcare

Xinhua III of Ziguang Co., Ltd. won the first place in China's 200g / 400g switch market share in 2021h1

Healthcare · Analysis

EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）

Private enterprises are actively embracing the transformative era

Sep 28, 2023 10:00 AM

Healthcare

Lanja has completed the Series A funding of hundred millions CNY

Shanghai Lanja Medical Technology Co., Ltd (“Lanja”) recently has announced the completion of the Series A funding of hundred millions CNY.

Sep 11, 2023 10:04 PM

Briefing Oct 19, 2021 06:56 AM · Financials

The investment banking business was strictly supervised, and seven securities companies received fines

Briefing Oct 17, 2021 06:26 PM · Healthcare

The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%

Briefing Sep 24, 2021 11:28 AM · Healthcare

The medical and American plate rose sharply

Healthcare

RabPharma has completed the Series A+ funding of hundred millions CNY

Zhongshan RabPharma Biopharmaceutical Co., Ltd. (“RabPharma”) recently has announced the completion of the Series A+ funding of hundred millions CNY.

Sep 05, 2023 10:17 AM

Healthcare

Powertight has completed a pre-Series A funding of hundred millions CNY

Powertight Biotechnology (Hangzhou) Co., Ltd. (“Powertight”) recently has announced the completion of a pre-Series A funding of hundred millions CNY.

Sep 04, 2023 11:43 AM

Briefing Aug 23, 2021 07:46 PM · Healthcare

AMEC: the net profit in the first half of the year was 425 million yuan, a year-on-year increase of 188.86%

Briefing Aug 02, 2021 10:06 AM · Healthcare | Automotive

Yimei concept stocks weakened in early trading, and Huaxi biology fell more than 10%

Briefing Jul 26, 2021 09:59 AM · Technology | Healthcare | Financials

Skyworth Digital: at present, the order volume of mini LED is sufficient and the production capacity is guaranteed

Briefing Jul 08, 2021 07:41 PM · Financials

Aimike's reply to the letter of concern: after obtaining the equity of huons bio, it will not have a significant adverse impact on the company's production and operation

EqualOcean Analysis